查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198542

外科牽開器市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Surgical Retractor Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，手術牽開器市場預計將以 7.1% 的複合年增長率增長。

COVID-19 大流行導致許多手術被取消，暫時影響了市場。 手術延期，手術次數減少。 JAMA Network Open 在 2021 年 12 月發表的一項研究發現，在美國，在擇期手術最初暫停期間，整體手術率與 2019 年同期相比下降了 48.0%，這就是我的意思。 外科手術的減少導致對外科牽開器的需求減少。 在大流行期間選擇急診手術患者至關重要，以確保術後儲備以應對感染 COVID-19 的可能性。 因此，在 COVID-19 大流行期間手術數量減少，影響了市場的增長。 然而，世界各地已恢復推遲的手術，這正在推動大流行後的市場增長。

需要手術的慢性疾病手術數量正在增加，例如外傷、髖/膝關節置換術和心血管疾病。 這是手術牽開器市場的主要增長因素。 例如，2021 年 6 月發表在《胸心血管外科雜誌》上的一項調查研究發現，共有 92,809 例手術被歸類為經典意義上的心臟手術，其中 29,444 例為單冠狀動脈旁路移植術，35,469 例為單心臟瓣膜手術2020 年手術和單心移植手術增加了 2%，達到 340 例。 因此，預計在預測期內，心臟手術和外科手術的高發率將推動手術牽開器市場的增長。

老年人口的持續增長可能會促進市場的增長。 根據世界衛生組織 2022 年 10 月的更新，到 2030 年，地球上每 6 個人中就有 1 人將超過 60 歲。 預計 60 歲及以上的人口將從 2020 年的 10 億增長到 2050 年的 14 億。 到 2050 年，世界 60 歲以上的人口預計將翻一番，達到 21 億。 2020 年至 2050 年間，80 歲及以上的人口數量預計將增加兩倍，達到 4.26 億。 預計全球老年人口的增加將推動市場增長，因為這個年齡段的人容易患慢性病和手術。 器官移植的增加也有望推動市場增長。 根據HSRA 2022年3月公佈的數據，2021年美國進行了約4萬例器官移植。 2021 年，美國進行了 26,670 例腎臟移植和 9,236 例活體供體移植。

市場參與者採取的各種舉措，例如產品發布、併購和合作夥伴關係，預計將在預測期內推動市場增長。 2021 年 4 月，美敦力 PLC 建立了合作夥伴關係，將 Surgical Theater 的 SyncAR 增強現實（ AR ）技術與美敦力的 StealthStation S8 手術導航系統連接起來。 該合作夥伴關係將使神經外科醫生能夠實時使用 AR 技術來增強複雜顱骨手術過程中的可視化效果，在某些情況下，還可以增強手術過程中牽開器和其他手術器械的放置。

上述因素預計將推動全球市場增長。 然而，缺乏足夠的醫療報酬和對微創手術的偏好增加預計將阻礙預測期內手術牽開器市場的增長。

手術牽開器市場趨勢

骨科牽開器領域有望佔據主要份額

根據應用，由於骨科手術的增加，骨科牽開器部分預計將保持較高的複合年增長率。 老年人口的增加、導致骨科疾病的事故數量增加以及全球髖關節和膝關節置換手術等因素正在推動這一領域的增長。

根據美國公路交通安全管理局 2022 年 5 月發布的數據，2021 年的交通死亡人數比 2020 年上升了 10.5%。 城市道路死亡人數從 2020 年 3 月的 57.0% 上升到 2021 年 3 月的 62.0%，增幅為 5.0%。 根據世界衛生組織2022年6月發布的數據，道路交通傷害是年輕人（5-29歲）和兒童死亡的主要原因之一。 世界上約 93.0% 的死亡主要發生在低收入和中等收入國家。 由於事故案例的增加，全世界截肢的人數都在增加。 例如，國家醫學圖書館 2022 年 1 月發表的一篇論文發現，2005 年截肢患病率為 160 萬，預計到 2050 年將翻一番。 上肢截肢的主要原因之一是外傷，佔後天截肢的近80.0%。 外科牽開器常用於上肢截肢手術。 預計此類實例將在預測期內推動該細分市場的增長。

上述因素預計將推動骨科手術牽開器的需求，推動預測期內該細分市場的增長。

北美將佔據很大的市場份額，預計在預測期內也會如此

北美預計將在預測期內主導市場。 在北美，由於老年人口不斷增長、患者人數眾多以及外科手術數量不斷增加，美國占據了很大份額。 預計在預測期內，婦科手術、腹部手術、心胸外科和骨科手術等手術數量的增加將增加對手術牽開器的需求。

根據阿拉巴馬大學伯明翰分校 2021 年 4 月的數據，美國每年進行 350,000 例 CABG 手術。 心血管疾病患病率上升和肥胖率上升是推動該地區市場增長的因素。 例如，根據 CDC 的 2022 年更新，有 1820 萬成年人患有冠狀動脈疾病，其中約 70% 的患者接受了手術。 美國每年記錄的住院人數約為 3500 萬。 因此，預計此類醫院入院和手術的增加將推動市場增長。 美國不斷上升的交通傷害導致外科手術的增加，這反過來又增加了手術牽開器的使用。 根據 ASIRT 於 2022 年 3 月發布的數據，每年有 440 萬美國人遭受需要就醫的重傷。

根據 Surgical Endoscopy 於 2021 年 11 月發表的一項研究，腹腔鏡膽囊切除術是美國最常見的腹部外科手術，每年進行的手術超過 750,000 例。僅此而已。 手術牽開器用於這些手術，預計將促進該國的市場增長。

因此，上述因素預計將在預測期內推動北美市場的增長。

手術牽開器市場競爭者分析

手術牽開器市場高度分散且競爭激烈。 市場參與者正專注於新產品發布、創新和地域擴張，以鞏固市場份額。 主要市場參與者包括 Johnson & Johnson (Ethicon)、Becton Dickinson & Company、B. Braun Melsungen AG、Medtronic Plc、Cook Group Inc。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 全球外科手術數量增加
    • 老年人口和生活方式相關疾病的增加
  • 市場製約因素
    • 缺乏足夠的醫療報酬
    • 越來越喜歡微創手術
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按類型
    • 手持設備
    • 自我保留
  • 通過申請
    • 骨科牽開器
    • 腹部固定裝置
    • 心臟/胸腔牽開器
    • 婦產科牽開器
    • 其他用途
  • 最終用戶
    • 醫院
    • 門診手術中心
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Johnson and Johnson（Ethicon）
    • Becton, Dickinson and Company
    • B. Braun Melsungen AG
    • Medtronic PLC
    • Cook Group Incorporated
    • Safe Orthopaedics
    • OBP Medical Corporation
    • Teleflex Incorporated
    • Medline Industries
    • BR Surgical

第7章 市場機會與今後動向

簡介目錄
Product Code: 68498

The surgical retractors market is expected to register a CAGR of 7.1% over the forecast period.

The COVID-19 pandemic resulted in the cancellation of many surgeries, which had a temporary impact on the market. Surgical procedures were delayed, and the number of surgical procedures decreased. According to a study published in December 2021 by JAMA Network Open, the overall rate of surgical procedures decreased by 48.0% during the initial shutdown of elective procedures compared to the same period in 2019 in the United States. This decline in surgical procedures led to decreased demand for surgical retractors. The selection of patients for urgent surgery during the pandemic was vital to ensure that patients had post-operative reserves to combat any possibility of being infected with COVID-19. Thus, the reduction in the number of surgical procedures during the COVID-19 pandemic affected the market's growth. However, the postponed surgeries resumed worldwide, which has been driving the market's growth during the post-pandemic period.

The number of surgical procedures due to trauma, hip and knee replacements, and chronic diseases such as cardiovascular diseases where surgery is mandatory is growing. This is the primary growth factor for the surgical retractor market. For instance, as per the research study published in June 2021 by the Journal of Thoracic and Cardiovascular Surgery, a total of 92,809 operations were classified as heart surgery procedures in the classical sense, of which 29,444 were isolated coronary artery bypass grafting procedures, 35,469 were isolated heart valve procedures, and the number of isolated heart transplantations increased by 2% to 340 in 2020. Hence, the high number of heart procedures and operations being performed is expected to boost the growth of the surgical retractors market during the forecast period.

The consistent rise in the geriatric population may boost the market's growth. According to the WHO updates from October 2022, one out of every six people on the planet will be 60 years of age or older by 2030. The number of people aged 60 and up is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. By 2050, the global population of people aged 60 and above will have doubled to reach 2.1 billion. During 2020-2050, the number of people aged 80 and above is expected to triple, reaching 426 million. Since this age group is more vulnerable to chronic disorders and surgeries, the growing geriatric populace across the world is expected to boost the market's growth. An increase in organ transplants may support the market's growth. According to the data published by the HSRA in March 2022, about 40,000 organ transplants were performed in the United States in 2021. In addition, 26,670 kidney transplants and 9,236 live transplants were performed in the United States in 2021.

Various initiatives taken by the key market players, such as product launches, mergers, acquisitions, and partnerships, are expected to boost the market's growth during the forecast period. In April 2021, Medtronic PLC formed a partnership to interface Surgical Theater's SyncAR augmented reality (AR) technology with Medtronic's StealthStation S8 surgical navigation system. This collaboration will enable neurosurgeons to use AR technology in real-time to enhance visualization during complex cranial procedures and possibly the placement of retractors and other surgical instruments during surgeries.

The above-mentioned factors are expected to drive the market's growth across the world. However, the lack of sufficient reimbursement and the increasing preference for minimally invasive surgery are expected to hamper the growth of the surgical retractor market during the forecast period.

Surgical Retractors Market Trends

Orthopedic Retractors Segment is Expected to Hold a Major Share

By application, the orthopedic retractors segment is anticipated to register a significant CAGR due to the growing number of orthopedic procedures. Factors such as the growing geriatric population, the rising number of accidents leading to permanent orthopedic ailments, and hip and knee replacement procedures around the world are driving the segment's growth.

According to the data published by the National Highway Traffic Safety Administration in May 2022, traffic fatalities increased by 10.5% in 2021 from 2020. Fatalities on urban roads increased from 57.0% in March 2020 to 62.0% in March 2021, registering a growth of 5.0%. According to the data published by the WHO in June 2022, road traffic injuries are one of the leading causes of death among young adults (aged 5 to 29 years) and children. Around 93.0% of the world's fatalities mostly occur in middle- and low-income countries. The increase in accident cases has increased the number of amputations across the world. For instance, according to the article published by the National Library of Medicine in January 2022, the prevalence of amputations was 1.6 million in 2005, which is expected to double by 2050. One of the major causes of upper limb amputations is trauma, which accounts for almost 80.0% of acquired amputations. Surgical retractors are commonly used for amputation surgery. Such instances are anticipated to drive the segment's growth over the forecast period.

The above-mentioned factors are anticipated to propel the demand for orthopedic surgical retractors, driving the segment's growth during the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the market over the forecast period. In North America, the United States held a significant share of the market due to the increasing geriatric population, a large patient population, and a growing number of various surgical procedures. Growth in the number of surgeries, such as gynecological, abdominal, cardiothoracic, and orthopedic surgeries, is expected to boost the demand for surgical retractors during the forecast period.

According to the April 2021 data of the University of Alabama at Birmingham, every year, 350,000 CABG surgeries are performed in the United States. The rising prevalence of cardiovascular disorders and obesity rates is attributed to the market's growth in this region. For instance, according to the CDC's 2022 update, 18.2 million adults had coronary artery disease, and approximately 70% of these patients underwent surgery. The United States records nearly 35 million hospital stays each year. Hence, this rise in hospital stays and surgeries is expected to drive the market's growth. The increasing number of injuries due to road accidents in the United States resulted in increased surgical procedures, thereby increasing the usage of surgical retractors. According to the data published in March 2022 by ASIRT, annually, 4.4 million Americans are injured seriously enough to require medical attention in the United States.

According to a study published in November 2021 by Surgical Endoscopy, laparoscopic cholecystectomy is the most common abdominal surgical treatment in the United States, with over 750,000 procedures performed annually. These procedures use surgical retractors, which is expected to boost the market's growth in the country.

Thus, the aforementioned factors are expected to boost the market's growth in North America over the forecast period.

Surgical Retractors Market Competitor Analysis

The surgical retractors market is highly fragmented and competitive. Market players focus on new product launches, innovations, and geographical expansion to strengthen their market share. The key market players include Johnson & Johnson (Ethicon), Becton, Dickinson and Company, B. Braun Melsungen AG, Medtronic Plc, and Cook Group Incorporated, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Number of Surgical Procedures Worldwide
    • 4.2.2 Increasing Geriatric Population and Lifestyle Related Diseases
  • 4.3 Market Restraints
    • 4.3.1 Lack of Sufficient Reimbursement
    • 4.3.2 Increasing Preference Towards Minimally Invasive Surgery
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Hand Held
    • 5.1.2 Self Retaining
  • 5.2 By Application
    • 5.2.1 Orthopedic Retractors
    • 5.2.2 Abdominal Retractors
    • 5.2.3 Cardiothoracic Retractors
    • 5.2.4 Obstetric or Gynaecological Retractors
    • 5.2.5 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Johnson and Johnson (Ethicon)
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 B. Braun Melsungen AG
    • 6.1.4 Medtronic PLC
    • 6.1.5 Cook Group Incorporated
    • 6.1.6 Safe Orthopaedics
    • 6.1.7 OBP Medical Corporation
    • 6.1.8 Teleflex Incorporated
    • 6.1.9 Medline Industries
    • 6.1.10 BR Surgical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS